590782388 | oh | 87702030 | | 4145081 | 10/21/2005 12:00:00 am | right mca stroke | | dis | admission date: 10/21/2005 report status:discharge date: 6/18/2005 final discharge orders trevethan , jerald 185-13-97-9villeservice: neudischarge patient on: 9/19/05 at 02:00 pmcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: branscum , brenton , m.d.code status:full codedisposition: rehabilitationdischarge medications:ciprofloxacin 500 mg po q12h x 10 dosesfood/drug interaction instructionadminister iron products a minimum of 2 hours before orafter a levofloxacin or ciprofloxacin dose doseif on tube feeds , please cycle ( hold 1 hr before to 2 hrafter ) take 2 hours before or 2 hours after dairy products.dextroamphetamine sulfate 10 mg po qdcolace ( docusate sodium ) 100 mg po bidinsulin regular humansliding scale ( subcutaneously ) sc tidif bs is less than 125 , then give 0 units subcutaneouslyif bs is 125-150 , then give 2 units subcutaneouslyif bs is 151-200 , then give 3 units subcutaneouslyif bs is 201-250 , then give 4 units subcutaneouslyif bs is 251-300 , then give 6 units subcutaneouslyif bs is 301-350 , then give 8 units subcutaneouslyif bs is 351-400 , then give 10 units subcutaneously andcall ho call ho if bs is greater than 400levothyroxine sodium 125 mcg po qdativan ( lorazepam ) 0.5 mg po q4h prn anxietymetoprolol tartrate 12.5 mg po bid hold if: sbp<120food/drug interaction instructiontake consistently with meals or on empty stomach.senna tablets ( sennosides ) 2 tab po bidsimvastatin 20 mg po qhsfood/drug interaction instructionavoid grapefruit unless md instructs otherwise.remeron ( mirtazapine ) 7.5 mg po qhsnumber of doses required ( approximate ): 5lamictal ( lamotrigine ) 200 mg po bidnumber of doses required ( approximate ): 5clopidogrel 75 mg po qd starting today ( 11/24 )hold if: plt count < 100duoneb ( albuterol and ipratropium nebulizer )3/0.5 mg neb q6h prn shortness of breathniaspan ( nicotinic acid sustained release ) 0.5 gm po qhsstarting today ( 11/24 ) hold if: myalgiasalert overridden: override added on 9/19/05 by :potentially serious interaction: simvastatin & niacin ,vit. b-3 reason for override: will monitorsalt tablet ( sodium chloride ) 1 gm po biddiet: mechanical soft/thin ( no consistency restriction ) (fdi)diet: house / low chol/low sat. fatdiet: house / ada 2100 cals/dyreturn to work: not applicablefollow up appointment( s ):dr. hegg , mhs 622-840-9570 2 weeks ,pcp dr. babiracki 547-466-8501 3-4 weeks ,neurologist dr. stencil asap ,oncologist dr. calvello as previously determined ,allergy: demerol , penicillins , codeine , sulfa , iv contrast ,levetiracetam , divalproex sodiumadmit diagnosis:strokeprincipal discharge diagnosis ;responsible after study for causing admission )right mca strokeother diagnosis;conditions , infections , complications , affecting treatment/staysevere right internal carotid artery stenosisnon-small cell lung cancer , pancytopenia secondary to chemotherapyhypertension , dyslipidemia , type 2 diabetes mellitus epilepsychronic obstructive pulmonary disease hypothyroidism ( post-graves' disease )siadhoperations and procedures:other treatments/procedures ( not in o.r. )mri/mra head and neckct/cta head and necknoncontrast head ct x 4video swallowing studytransthoracic echocardiogrambrief resume of hospital course:this 64 year-old right-handed woman presented after being found down andweak on the left. she has a recent diagnosis of non-small cell lungcancer and has been receiving chemotherapy and radiation therapytreatments. she presented outside the window for thrombolysis orintervention. exam revealed plegia of the left face and arm , paresis ofthe left leg , and an incomplete neglect syndrome. mri/mra revealedpartial right mca territory stroke and suggested severe proximal rightica stenosis; she was placed on heparin. antihypertensives , aside fromlow-dose metoprolol , were held. ct/cta head and neck the following dayconfirmed a severe proximal right ica stenosis and revealed evolution ofthe stroke to involve much of the right mca territory. the heparin wasdiscontinued and the patient placed back on clopidogrel. the hoaggan memorial hospitalunder dr. aiu evaluated the patient and recommended a follow-upappointment with him two weeks after discharge.laboratory work-up pertinent to stroke revealed a normal homocysteine ,normal tsh , lipid profile with ldl 108 , hdl 52 , tg 131 , and lp( a )lipoprotein elevated at 93. she was continued on a statin , and low-doseniacin added to the regimen because of the lp( a ) results. her hemoglobina1c and random blood sugars were elevated; she received an insulinsliding scale. echocardiogram showed normal lvef and size , no wall motionabnormalities , + evidence of diastolic dysfunction , and normal la size.her cell counts trended downward in an expected fashion given the timingof her most recent chemotherapy. she was placed on neutropenicprecautions. her oncologist dr. batrez recommended administeringprophylactic ciprofloxacin and a single dose of long-acting g-csf. she isnot planned to receive any additional chemotherapeutic or radiationtherapy treatments in the near future.her neurological examination remained stable. repeat head cts done toassess for edema following the stroke revealed some effacement of theright lateral ventricle , but no threatening mass effect.her serum sodium trended down throughout admission; it is recommendedthat she not receive hypotonic fluids at rehab and that she be waterrestricted to 1l per day , and take salt as directed.given her thrombocytopenia , it is recommended that antiplatelet therapywith clopidogrel be held until her platelet count rises over 100. it isalso recommended that anticoagulation with therapeutic low-molecularweight heparin as bridge to warfarin with target inr 2-3 be restarted 2weeks after her stroke , on 2/16/05. she should follow up forneurological issues with dr. sagan of neurosurgery as well as heroutpatient neurologist , dr. collin krauskopf , at cako hospitaladditional comments:discharge condition: fairto do/plan:1. hold clopidogrel until plt > 100k2. start low-molecular weight heparin as a bridge to warfarin ( target inr2-3 ) and discontinue clopidogrel 7/1/053. free water restrict 1l per day , follow serum sodium.4. follow up with dr. amoah in 2 weeks.no dictated summaryentered by: napolitano , clint ray , m.d. ( iq99 ) 9/19/05 @ 02 end of discharge orders 